Skip to main content

Athenex, Inc.

ATNXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001300699

Athenex, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on May 8, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $2.43M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Athenex, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ATNX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7772−5
Shares35.7M48.1M+12.4M (+34.9%)
Value$14.7M$13.0M−$1.70M (−11.6%)

New holders (13)

Institutions that held Athenex, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ATNX in Q3 2022
InstitutionSharesValue% of portfolio
CVI Holdings, LLC2,626,943$708.0K0.05%
Alyeska Investment Group, L.P.2,000,000$539.0K0.01%
Empery Asset Management, LP1,452,103$391.0K2.33%
AIGH Capital Management LLC1,000,134$269.0K0.11%
Endurant Capital Management LP526,651$142.0K0.05%
Worth Venture Partners, LLC248,832$67.0K0.04%
Tudor Investment Corp Et Al228,105$61.0K0.00%
Warberg Asset Management LLC35,500$10.0K0.00%
ProShare Advisors LLC13,212$4.00K0.00%
Two Sigma Securities, LLC11,161$3.00K0.00%
Bayesian Capital Management, LP12,200$3.00K0.00%
McCollum Christoferson Group LLC10,000$3.00K0.00%
China Universal Asset Management Co., Ltd.1,471$00.00%

Sold out (18)

Institutions that held Athenex, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.